XML 55 R44.htm IDEA: XBRL DOCUMENT v3.25.2
Equity Method Investment (Details) - USD ($)
2 Months Ended 3 Months Ended 6 Months Ended
Feb. 26, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Mar. 31, 2025
Dec. 31, 2024
Feb. 09, 2024
Feb. 09, 2023
Equity Method Investment [Line Items]                
Equity method investments, net         $ 10,636,544    
Purchased interests     20,666,667          
Cash     201,532     2,856,309    
Preferred stock, value            
Cost of investment               $ 19,460,000
Estimated useful life     15 years          
Loss from equity method investment   $ (329,337) $ 392,677 $ (221,868)        
Distribution of earnings     1,745,000          
Series B Preferred Stock [Member]                
Equity Method Investment [Line Items]                
Equity method investments, net $ 11,000,000              
Preferred stock, value         $ 11,000,000    
Issuance shares (in Shares)     0     11,000    
Conversion price per share (in Dollars per share)     $ 56.7          
Series B Convertible Preferred Stock [Member]                
Equity Method Investment [Line Items]                
Equity method investments, net         $ 11,029,221      
Preferred stock, value     $ 1,000          
Conversion price per share (in Dollars per share)     $ 56.7          
Aggregate of common stock (in Shares)     194,004          
Laboratory Services MSO [Member]                
Equity Method Investment [Line Items]                
Ownership percentage 40.00%   40.00%          
Cash     $ 9,000,000          
Amortization expense $ 111,156 166,733   333,466        
Loss from equity method investment 503,833 162,604   111,589        
Distribution of earnings $ 0 $ 312,465   $ 473,253        
Avalon Lab [Member]                
Equity Method Investment [Line Items]                
Total ownership percentage 40.00%              
Avalon Lab [Member] | Series B Preferred Stock [Member]                
Equity Method Investment [Line Items]                
Preferred stock, value     $ 11,000,000          
Issuance shares (in Shares)     11,000          
Avalon Lab [Member] | Series B Stated Value [Member]                
Equity Method Investment [Line Items]                
Preferred stock, value     $ 1,000          
Unrelated Company [Member]                
Equity Method Investment [Line Items]                
Total ownership percentage 60.00%              
Series B Stated Value [Member]                
Equity Method Investment [Line Items]                
Equity method investment payable             $ 666,667